Marco RUSNATI

full professor

University of Brescia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marco Rusnati is a full professor at the University of Brescia, Italy. His research primarily focuses on drug repositioning, glycosaminoglycans, and their roles in viral interactions and foundational processes in pharmacology. Recent articles authored by Prof. Rusnati explore innovative strategies in the pharmacokinetics of therapeutic compounds and the molecular dynamics of viral infections. His work significantly contributes to advancements in CFTR drug discovery and the development of therapeutic agents against various viruses.

Articles (9)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Federica Vacondio

Associate Professor

Università degli Studi di Pavia

ITALY

View details

Marco Mor

Università degli Studi di Pavia

ITALY

View details

Rafael Gómez

Universidad de Alcalá

SPAIN

View details

Alessio Lodola

Associate Professor of Medicinal Chemistry

Università degli Studi di Pavia

ITALY

View details

Robert Ford

Professor

The University of Manchester

UNITED KINGDOM

View details

Massimiliano Tognolini

Associate professor

Università degli Studi di Pavia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco RUSNATI

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing

Prevention of Herpesviridae Infections by Cationic PEGylated Carbosilane Dendrimers

Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice

HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration

A Bittersweet Computational Journey among Glycosaminoglycans

In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library

Recent Strategic Advances in CFTR Drug Discovery: An Overview

Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays

Collaborators (6)

Federica Vacondio

Marco Mor

Rafael Gómez

Alessio Lodola

Robert Ford

Massimiliano Tognolini

Make your next move.